Ultromics Raises $55M to Fix Heart Disease’s Biggest Detection Problem
Oxford-based Ultromics closed a $55 million Series C round to expand its artificial intelligence platform that spots hidden heart disease in routine ...
Read moreDetailsOxford-based Ultromics closed a $55 million Series C round to expand its artificial intelligence platform that spots hidden heart disease in routine ...
Read moreDetails